Although adults with Attention Deficit Hyperactivity Disorder (ADHD) can benefit from medications commonly used to treat the disorder in children, there is variation in their use across Canada and some of the drugs can be difficult to access, says a report released by the Ontario Drug Policy Research Network (ODPRN) with collaboration from St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences (ICES).
ICES scientist Tara Gomes, the report's lead researcher, discusses the report.
Visit our YouTube page to view the video.
